Schnell Biopharmaceuticals Incorporation operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Schnell Biopharmaceuticals Incorporation with three other
companies in this sector in South Korea:
Seoul Pharma Co., Ltd.
sales of 45.92 billion Korean Won [US$41.10 million]
DHP Korea Co Ltd
(44.72 billion Korean Won [US$40.02 million]
Pharma Reaserch Products Co Ltd
(45.95 billion Korean Won [US$41.13 million]
During the year ended December of 2016, sales at
Schnell Biopharmaceuticals Incorporation were 44.12 billion Korean Won (US$39.49 million).
increase of 9.4%
versus 2015, when the company's sales were 40.32 billion Korean Won.
This was the third consecutive year of growth at Schnell Biopharmaceuticals Incorporation.